venture
-
Telormedix secures further funding
Telormedix announced that it has raised 7.5 million CHF (US$8.1 million) from existing investors Aravis Venture and Proquest Investments.
venture | 17 February 2012
-
FUJIFILM, Dr Reddy's establish exclusive joint venture on generic drugs in Japan
FUJIFILM Corporation President and CEO, Shigetaka Komori and Dr Reddy's Laboratories Ltd Vice-Chairman and CEO, G V Prasad signed a memorandum of understanding to enter into an exclusive partnership in the generic drugs business for the Japanese mark…
venture | 29 July 2011
-
Merck and Simcere to establish China joint venture
Merck & Co Inc and China’s Simcere Pharmaceutical Group announced the signing of a framework agreement to establish a joint venture focused on serving China's rapidly expanding health care needs by providing significantly improved access to quality…
venture | 25 July 2011
-
MingSight and Relin form joint venture in China
Shenzhen Relin Medicine and MingSight Pharmaceuticals announced the formation of a joint venture, Jiangsu MingSight-Relin Pharmaceutical Co Ltd to develop and commercialize an innovative treatment for diabetic eye disease in China. MingSight-Relin…
venture | 07 July 2011
-
Merck and Simcere to establish China joint venture
Merck & Co Inc and China's Simcere Pharmaceutical Group announced the signing of a framework agreement to establish a joint venture focused on serving China's rapidly expanding health care needs by providing significantly improved access to quality m…
venture | 01 July 2011
-
Sanofi-aventis and Medicines for Malaria Venture join forces
Sanofi-aventis and Medicines for Malaria Venture (MMV) announced that they have signed an alliance agreement to research malaria treatments as well as the first research project agreement within the framework of the alliance. As part of the agreem…
venture | 05 May 2011
-
Sequella, Maxwell Biotech Venture sign agreement on SQ109 for tuberculosis
Deal valued at over $100 million to the parties.
venture | 26 April 2011
-
Merck, Sun Pharma establish joint venture on generics
Joint venture to apply proprietary technologies to develop medicines designed to enhance convenience and improve compliance
venture | 12 April 2011
-
Ascletis raises $100 million for specialty therapeutics venture
Ascletis Inc, a US-China specialty life sciences venture focused on cancer and infectious disease therapeutics, announced the company’s formation and completion of a Series A private equity financing. Ascletis has raised US$100 million in committed…
venture | 07 April 2011
-
Mitsui Ventures invests US$5 million in S*BIO
A US$5 million investment by Mitsui Ventures will support the continued development of S*BIO’s clinical programs. “Mitsui Ventures’ financing commitment reflects the international investment community’s strong interest in our track recor…
venture | 01 October 2010
